Explore our certified CRO methodologies and contract manufacturing suites engineered for rigorous international regulatory compliance.
Transitioning empirical ethnopharmacology into molecularly quantified, reproducible, and verifiable industrial biomanufacturing solutions.
Years Focused on Natural Medicine R&D
Senior Research Scientists & Analytical Chemists
Classic TCM Formulations Fully Modernized
Single-Herb Active Reference Standards Established
Moving past arbitrary extract ratios (such as unstandardized 10:1 or 20:1 claims), our platform establishes molecular proportionality across primary and secondary glycosides, flavonoids, polysaccharides, and volatile terpenes to ensure bio-equivalent pharmacodynamics.
Every precise ratio formulation undergoes comprehensive in vitro cellular binding assays and enzymatic inhibition testing, identifying synergistic target pathways while systematically excluding cytotoxic antagonistic compounds.
From geo-authenticated botanical procurement across distinct Chinese agricultural terroirs to validated HPLC, GC-MS, and HPTLC fingerprint matrices, our precise proportioning guarantees uncompromising global regulatory audit readiness.
How precise proportional formulation overcomes raw biomass variance, regulatory shifts, and commercialization barriers worldwide.
Agricultural botanical crops experience inevitable shifts in active molecule density driven by rainfall fluctuations, soil microbiome dynamics, and harvest timelines. As a premier China Precise Proportions Supplier, MedGence solves this via adaptive algorithmic proportioning—dynamically blending analytical fraction batches to achieve mathematically locked therapeutic specs across multi-ton production cycles.
Agencies such as the US FDA (21 CFR Part 111/312), the European Medicines Agency (EMA Committee on Herbal Medicinal Products - HMPC), and Australia's TGA have accelerated scrutiny over botanical drug substance identity and contamination markers. Our precision CDMO protocols enforce stringent threshold limits for pesticide residues, heavy metals, residual solvents, and polycyclic aromatic hydrocarbons (PAHs).
By uniting end-to-end CRO capabilities (in vitro bioassays, animal pharmacokinetic models, toxicity profiling, and Phase I–IV clinical designs) directly with our managed industrial pilot plants, global brands eliminate the 12–18 month friction loop typical when transferring laboratory formulation assays to third-party contract manufacturers.
Engineered therapeutic and wellness delivery systems designed for high bioavailability, exceptional matrix stability, and consumer compliance.
Modern consumers require verifiable, clinically validated outcomes. We supply precise proportion compounds for metabolic regulation, sleep architecture optimization, immune modulatory beverages, and cognitive health. Formats feature micro-encapsulated water-soluble powders, clean-label effervescents, direct-compression chewables, and functional drops with masked organoleptic bitterness.
For research universities, biotechs, and pharmaceutical titans, we deliver comprehensive Investigational New Drug (IND) scientific filing portfolios. Drawing from our track record of 22 innovative natural medicines, 56 hospital preparation approvals, and modern analysis of 83 classic TCM formulations, our proportioning provides verified pharmacokinetics (PK/PD) and clean toxicological safety margins.
Targeting anti-senescence, transdermal barrier fortification, and cellular melanogenesis inhibition. We develop sub-micron emulsion matrices, botanical nano-carriers, and clarified lipid suspensions ensuring maximum stratum corneum penetrability while maintaining pristine solution clarity, photostability, and complete absence of skin irritation.
A multi-layered scientific infrastructure engineered to withstand multinational regulatory audits and protect critical corporate IP.
Our Changsha testing centers deploy state-of-the-art HPLC-DAD, LC-MS/MS, GC-FID, and high-performance thin-layer chromatography (HPTLC) systems to cross-verify reference standards, eliminate baseline noise, and confirm molecular weights down to trace isomer fractions.
Every batch produced under our CDMO protocol undergoes certified testing for over 400 organochlorine and organophosphate pesticides, heavy metals (ICP-MS for Pb, Cd, As, Hg), mycotoxins (Aflatoxin B1/G1, Ochratoxin A), and irradiation markers to exceed EU/USP pharmacopoeial statutes.
We operate under an exclusive entrusted contract development and manufacturing paradigm. Complete non-disclosure frameworks, segmented lab access, and strictly compartmentalized batch manufacturing records ensure your proprietary active fractions and formulas remain fully safeguarded.
Global regulatory clearance requires meticulous paper trails. Our dedicated international regulatory compliance desk prepares complete Drug Master Files (DMF), Certificates of Analysis (COA), safety data packages (SDS), BSE/TSE statements, and non-GMO affidavits tailored to your regional port of entry.
How MedGence integrates predictive artificial intelligence, machine learning, and synthetic biology into botanical formulation.
Deploying deep-learning neural networks trained on phytochemical affinity databases to forecast receptor-ligand docking kinetics, reducing initial screening timelines from months to mere days.
Transitioning from traditional multi-step tank extractions to computerized counter-current supercritical fluid and microwave-assisted systems with integrated NIR (Near-Infrared) real-time feedback loops.
Leveraging tailored microbial fermentation and enzymatic bioconversions to convert low-activity precursor saponins and polyphenols into ultra-rare, high-potency bio-metabolites at industrial scale.
Engineering targeted lipid nanoparticles (LNPs) and liposomal phytosomes to bypass enzymatic gastrointestinal degradation, elevating bioavailability by up to 800% for complex botanical fractions.
Clear, definitive technical clarifications addressing supply chain mechanics, technical validation, and partnership execution.
Review our core active screening and preclinical testing pathways ready for rapid pilot deployment and volume production.
